Angiogenesis inhibitors are safe cancer drugs despite hypertension risk, panel concludes
Wednesday, May 12, 2010 - 22:30
in Health & Medicine
A new class of cancer drugs can be used effectively while minimizing hypertensive side effects if patients' blood pressure is closely monitored and controlled, a clinical panel has determined.